Blaskovic, S.; Donati, Y.; Ruchonnet-Metrailler, I.; Seredenina, T.; Krause, K.-H.; Pache, J.-C.; Adler, D.; Barazzone-Argiroffo, C.; Jaquet, V.
Di-Tyrosine Crosslinking and NOX4 Expression as Oxidative Pathological Markers in the Lungs of Patients with Idiopathic Pulmonary Fibrosis. Antioxidants 2021, 10, 1833.
https://doi.org/10.3390/antiox10111833
AMA Style
Blaskovic S, Donati Y, Ruchonnet-Metrailler I, Seredenina T, Krause K-H, Pache J-C, Adler D, Barazzone-Argiroffo C, Jaquet V.
Di-Tyrosine Crosslinking and NOX4 Expression as Oxidative Pathological Markers in the Lungs of Patients with Idiopathic Pulmonary Fibrosis. Antioxidants. 2021; 10(11):1833.
https://doi.org/10.3390/antiox10111833
Chicago/Turabian Style
Blaskovic, Sanja, Yves Donati, Isabelle Ruchonnet-Metrailler, Tamara Seredenina, Karl-Heinz Krause, Jean-Claude Pache, Dan Adler, Constance Barazzone-Argiroffo, and Vincent Jaquet.
2021. "Di-Tyrosine Crosslinking and NOX4 Expression as Oxidative Pathological Markers in the Lungs of Patients with Idiopathic Pulmonary Fibrosis" Antioxidants 10, no. 11: 1833.
https://doi.org/10.3390/antiox10111833
APA Style
Blaskovic, S., Donati, Y., Ruchonnet-Metrailler, I., Seredenina, T., Krause, K.-H., Pache, J.-C., Adler, D., Barazzone-Argiroffo, C., & Jaquet, V.
(2021). Di-Tyrosine Crosslinking and NOX4 Expression as Oxidative Pathological Markers in the Lungs of Patients with Idiopathic Pulmonary Fibrosis. Antioxidants, 10(11), 1833.
https://doi.org/10.3390/antiox10111833